Sepsis: Heterogeneity, Immunopathology, and Advances in Therapeutic Strategies
The FASEB Journal · 15.02.2026 · 40 (3)
DOI: 10.1096/fj.202503685r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 04.02.2026. Verfasst von Junxing Qu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Health Central Plains, Henan Medical University, Xinxiang, Henan, China. Hauptthemen laut MEDLINE: Sepsis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 149 Literaturangaben. Gefördert von: National Natural Science Foundation youth fund of China, Natural Science Foundation of Henan Province, Henan Medical University Research Launch Foundation.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a heterogeneous syndrome characterized by a dysregulated host response to infection resulting in life‐threatening organ dysfunction. It has emerged as one of the most critical causes of mortality worldwide, imposing not only substantial physical and economic burdens on patients and their families but also creating a significant strain on healthcare systems worldwide. Despite its severity, the absence of targeted effective therapeutics remains a disappointing and persistent challenge in clinical management. This underscores the urgent need to develop a more comprehensive understanding of sepsis and to elucidate its underlying pathophysiological mechanisms, which is essential for identifying novel therapeutic strategies. In this review, we synthesize recent advances in sepsis subphenotypes, diagnostic criteria, and associated complications, with particular emphasis on alterations in the host immune response. This includes an analysis of the functional states of key immune cells and the dynamic interplay between the host and gut microbiota. Furthermore, we discuss future directions and potential innovative treatments for sepsis. It is anticipated that this comprehensive overview may provide new perspectives and avenues for improving the prognosis and management of sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institutes of Health Central Plains, Henan Medical University, Xinxiang, Henan, China.
- Xinxiang Key Laboratory for Tumor Drug Screening and Targeted Therapy, Xinxiang, Henan, China.
- Department of Anesthesiology, Xinxiang First People's Hospital, The Affiliated People's Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
- College of Life Science, Institute of Biomedical Science, Henan Normal University, Xinxiang, Henan, China.
ORCID-Profile: Junxing Qu, Zhiheng Sun
Förderung
- National Natural Science Foundation youth fund of China
- Natural Science Foundation of Henan Province
- Henan Medical University Research Launch Foundation
- Henan Provincial Medical Science and Technology Research Joint Venture Project
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Qu, J., Li, P., & Sun, Z. (2026). Sepsis: Heterogeneity, Immunopathology, and Advances in Therapeutic Strategies. The FASEB Journal, 40(3). https://doi.org/10.1096/fj.202503685r
Vancouver
Qu J, Li P, Sun Z. Sepsis: Heterogeneity, Immunopathology, and Advances in Therapeutic Strategies. The FASEB Journal. 2026;40(3). doi:10.1096/fj.202503685r
BibTeX
@article{Qu2026,
author = {Qu, Junxing and Li, Peizhi and Sun, Zhiheng},
title = {Sepsis: Heterogeneity, Immunopathology, and Advances in Therapeutic Strategies},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {3},
doi = {10.1096/fj.202503685r}
}
EUVIMED